STTK - Shattuck Labs Inc

https://www.shattucklabs.com

Momentum: Bearish

Recent News

Shattuck Labs ( STTK ) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Commentary • 6 days, 18 hours ago • score: 0.32

Shattuck Labs (STTK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. The company is headquartered in Austin, Texas.

52W High

$3.95

52W Low

$0.69

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.65

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-3.62

EV/Revenue (<3 favorable)

8.93

P/S (TTM) (<3 favorable)

24.77

P/B (<3 favorable)

1.30

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

14.59%

Institutions (25–75% balanced)

72.19%

Shares Outstanding

47,903,200

Float

17,604,400

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

2,997,000

Gross Profit (TTM)

15,007,000

EPS (TTM)

-1.21

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-21.61%

ROE (TTM) (>15% strong)

-0.73%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-1.00

Momentum

Bearish momentum

Value

0.3362

0.3245

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025